MILAN, Feb 16 (Reuters) - Exor (EXOR.AS), opens new tab, the Agnelli family's investment vehicle, and the founder of Lifenet Healthcare have agreed to sell the Italian private clinics and diagnostics ...

Sometimes the parts are worth more than the whole. That’s the case with Exor, whose massive discount has created a low-risk bet for value-seeking investors.

Hello, and welcome to the Euronext Full Year 2025 Results Conference Call. On today's call, we have Stéphane Boujnah, CEO and Chairman of the Managing Board; and Giorgio Modica, CFO. Please note, this ...

Diamond Hill International Strategy returned 3.87% (net of fees) and the MSCI ACWI ex USA Index returned 5.05%. Sumitomo Densetsu, a Japanese electrical contractor, benefited from a takeover bid by ...

Analysts cut 2025 and 2026 EPS estimates after Stellantis skipped a 2025 payout, but they still kept a Buy rating and a €124 target. This stings more than it used to because Exor is now an “investment ...

Get the latest Exor N.V. (EXO.AS) stock news and headlines to help you in your trading and investing decisions.